Written by Marcia J. Egles, MD. Supplementation with the prebiotic inulin-type fructose in ApoE-Knock-out mice fed a PUFA-depleted diet for 12 weeks, totally reversed endothelial dysfunction in their carotid arteries and altered their gut microbiota and liver gene expression. (more…)
Lactobacillus rhamnosus HN001 may Prevent Postpartum Symptoms of Anxiety and Depression – Director’s Choice
Written by Angeline A. De Leon, Staff Writer. Lactobacillus rhamnosus HN001 significantly reduced symptoms of postpartum anxiety and depression in the intervention group of 112 women compared to those in the placebo group. (more…)
Written by Angeline A. De Leon, Staff Writer. Both high and low doses of a proprietary blend of Lactobacillus acidophilus, Lactobacillus paracasei Lpc-37, Bifidobacterium lactis BI-07, and Bifidobacterium lactis BI-04) were significantly more effective in lowering the development of antibiotic- associated diarrhea then the placebo in the 503 hospitalized patients requiring antibiotic treatment. (more…)
Written by Jessica Patella, ND. Pregnant women 35 years of age and older, who took Lactobacillus rhamnosus during their pregnancy, significantly reduced their risk of developing gestational diabetes compared to those in the control group.
Written by Angeline A. De Leon, Staff Writer. Of the 118 study participants, those who supplemented for eight weeks with Lactobacillus brevis (L. Brevis) SBC8803 significantly improved skin hydration compared to the placebo group. (more…)
Efficacy of Bifidobacterium Longum and Lactobacillus Acidophilus in Treatment of Rotavirus Infection in Infants
Written by Angeline A. De Leon, Staff Writer. Of the 57 hospitalized infants with retrovirus infection, those who were treated with a probiotic formula containing Bifidobacterium longum BORI and Lactobacillus acidophilus had significantly improved symptoms compared to those in the placebo group who were treated with a probiotics-free skim milk powder. (more…)
Written by Greg Arnold, DC, CSCS. Two weeks of intervention with Lactobacillus rhamnosus GG (LGG®) and Bifidobacterium (BB-12®) significantly reduced H. pylori infection and symptoms in the participating subjects compared to placebo. (more…)
Written by Angeline A. De Leon, Staff Writer. Four weeks of probiotic supplementation with B longum BB536, B infantis M63, and B breve M-16 V significantly improved symptoms of seasonal allergic rhinitis in the participating children compared placebo. (more…)
Written by Greg Arnold, DC, CSCS. Four weeks of treatment with a combination of 4 probiotics significantly reduced the severity and number of days of diarrhea in participating subjects who were suffering from an initial infection with Clostridium difficile. (more…)
Written by Greg Arnold, DC, CSCS. A symbiotic preparation of Lactobacillus plantarum ATCC strain 202195 in combination with the prebiotic fructooligosaccharide, when given orally to 2,278 newborns, significantly reduced diarrhea and death from sepsis and significantly increased weight gain compared to the placebo group.
Written by Joyce Smith, Staff Writer. Genotyping a cohort of children at high risk for eczema revealed that supplementing with Lactobacillus rhamnosus HN001 was more effective in modifying gene susceptibility to eczema than supplementing with Bifidobacterium animalis subsp lactis HN019. (more…)
Immune Function Improved by Dietary Intake of Yogurt Containing L. Paracasei, B. Lactis, and Heat-Treated L. Plantarum
Written by Angeline A. De Leon, Staff Writer. A twelve week daily consumption of dairy yogurt containing L. paracasei, B. lactis, and heat-treated L. plantarum enhanced the immune system functioning in 200 participating nondiabetic older adults. (more…)
Written by Greg Arnold, DC, CSCS. Study participants with gingivitis, who supplemented daily for 12 weeks with a probiotic containing Lactobacillus plantarum, significantly improved probing depth and plaque index compared to the control group.
Written by Marcia J. Egles, MD. Six months of supplementation with the probiotic Lactobacillus reuteri significantly improved the number of pulmonary exacerbations and hospitalizations and number of upper respiratory and gastrointestinal infections in the participating subjects with cystic fibrosis.
Written by Greg Arnold, DC, CSCS. Fifty Japanese study participants significantly improved their symptoms of eczema when they supplemented with the probiotic Saccharomyces cerevisisiae L92 for just 24 weeks.